Exponent, Inc. (NASDAQ:EXPO) Position Trimmed by American International Group Inc.

American International Group Inc. lessened its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,154 shares of the business services provider’s stock after selling 3,352 shares during the quarter. American International Group Inc.’s holdings in Exponent were worth $8,201,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Parkside Financial Bank & Trust grew its stake in shares of Exponent by 8.7% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,595 shares of the business services provider’s stock valued at $140,000 after buying an additional 127 shares in the last quarter. Quadrature Capital Ltd grew its stake in shares of Exponent by 6.7% in the 3rd quarter. Quadrature Capital Ltd now owns 2,452 shares of the business services provider’s stock valued at $210,000 after buying an additional 155 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Exponent by 1.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 12,442 shares of the business services provider’s stock valued at $1,065,000 after buying an additional 207 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of Exponent by 12.4% in the 4th quarter. Parallel Advisors LLC now owns 1,941 shares of the business services provider’s stock valued at $171,000 after buying an additional 214 shares in the last quarter. Finally, Kestra Advisory Services LLC grew its stake in shares of Exponent by 8.9% in the 3rd quarter. Kestra Advisory Services LLC now owns 2,816 shares of the business services provider’s stock valued at $241,000 after buying an additional 229 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Analysts Set New Price Targets

EXPO has been the subject of several recent research reports. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th. Truist Financial upped their target price on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, April 29th.

Insider Transactions at Exponent

In other news, insider Eric Guyer sold 1,650 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total transaction of $152,757.00. Following the completion of the transaction, the insider now directly owns 1,846 shares in the company, valued at $170,902.68. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, insider Eric Guyer sold 1,650 shares of the company’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the completion of the transaction, the insider now directly owns 1,846 shares in the company, valued at $170,902.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Paul R. Johnston sold 7,000 shares of the firm’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $95.50, for a total value of $668,500.00. Following the completion of the transaction, the director now directly owns 80,742 shares of the company’s stock, valued at $7,710,861. The disclosure for this sale can be found here. Insiders sold a total of 50,067 shares of company stock worth $4,734,995 over the last three months. 2.10% of the stock is currently owned by insiders.

Exponent Stock Down 0.1 %

Shares of Exponent stock opened at $96.48 on Thursday. The stock has a market capitalization of $4.89 billion, a P/E ratio of 48.73 and a beta of 0.65. The stock has a 50 day moving average price of $91.33 and a two-hundred day moving average price of $86.01. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $102.72.

Exponent (NASDAQ:EXPO) last announced its earnings results on Thursday, April 25th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.13. Exponent had a return on equity of 28.13% and a net margin of 18.72%. The firm had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. During the same quarter in the prior year, the business earned $0.56 earnings per share. The company’s revenue was up 6.6% on a year-over-year basis. Sell-side analysts anticipate that Exponent, Inc. will post 1.92 earnings per share for the current year.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be issued a dividend of $0.28 per share. The ex-dividend date is Friday, June 7th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.16%. Exponent’s dividend payout ratio (DPR) is presently 56.57%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.